arrow
S

Sahaj Rathi

pgimer
H指数:18
被引数:1,033

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Epidemiology, Predictors of Antimicrobial Resistance and Empiric Treatment Strategies for Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicentre SBP-INDIA Study

肝硬化自发性细菌性腹膜炎的流行病学、抗菌药物耐药性预测因子及经验性治疗策略:一项多中心SBP-INDIA研究

2026-05-130
PRE
Endoscopic Ultrasound-Guided Coiling Plus Glue Injection Compared With Other Endoscopic Modalities in Managing Gastric Varices: A Systematic Review and Meta-Analysis

内镜超声引导下线圈栓塞联合胶体注射与其他内镜方法在胃静脉曲张管理中的比较:一项系统评价和Meta分析

2025-12-010
OAAI
Corrigendum to “Clinical and pathophysiological characteristics of non-acute decompensation of cirrhosis” [J Hepatol (2025) https://doi.org/10.1016/j.jhep.2025.02.028]

勘误:“非急性肝硬变失代偿的临床和病理生理特征” [J Hepatol (2025) https://doi.org/10.1016/j.jhep.2025.02.028]

2025-09-250
PRE
Management of acute variceal bleeding: updated APASL guidelines

急性静脉曲张出血的管理:APASL指南更新

2025-08-310
PRE
Plasma Exchange With Corticosteroids as a Rescue Therapy for Severe Prolonged Cholestasis in Acute Viral Hepatitis

血浆置换联合糖皮质激素作为急性病毒性肝炎严重持续性胆汁淤积的挽救疗法

2025-05-200
PRE
Experience With Dabigatran on Rate of Portal Vein Thrombosis Recanalization, Disease Progression and Survival

达比加群对门静脉血栓再通率、疾病进展和生存率的影响

2025-01-031
PRE
Insulin-like Growth Factor-1 Levels Reflect Muscle and Bone Health and Determine Complications and Mortality in Decompensated Cirrhosis

胰岛素样生长因子-1水平反映肌肉和骨骼健康,并确定失代偿期肝硬化的并发症和死亡率

2025-01-011
PRE
Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program
2024-12-011
PRE